Buradasınız

Birinci basamak hekimleri serviks kanseri ve HPV aşısı ile ilgili ne biliyorlar?

What do primary care physicians know about cervical cancer and HPV vaccine?

Journal Name:

Publication Year:

DOI: 
doi:10.2399/tahd.11.001

Keywords (Original Language):

Abstract (2. Language): 
Objective: HPV vaccine enables primary prevention for cervical cancer. However, for its acceptance and usage by families, espe¬cially family physicians' recommendation is an important factor due to characteristics of the discipline. At this point physicians' level of knowledge can effect its recommendation. Our aim is to determine the level of knowledge about cervical cancer and HPV vaccine of primary care physicians. Methods: A descriptive cross-sectional designed study was car¬ried out with physicians working in Family Healthcare Centers in Izmir. A questionnaire including participants' demographic characteristics, and 18 questions about cervical cancer and HPV vaccine was applied. Data were analyzed by SPSS 15.0 software with chi-square, t-test, and ANOVA; p<0.05 was considered statistical¬ly significant. Results: Of the physicians, 61.3% were male. Their mean age and professional experience were 44.22±6.56 and 19.37±6.34 years, respectively. 22.0% of physicians thought their female population aged 15-49 years often had sexually transmitted diseases; however, 30.7% didn't recommend the vaccine to the target group. The most important barrier for the vaccine is believed to be its cost by 72.0%. Physicians' mean score of knowledge was 7.29±3.02 out of 18 points. Conclusions: Training of physicians about HPV vaccine enables them to develop correct attitudes and behaviors.
Abstract (Original Language): 
Amaç: HPV aşısı, serviks kanserinden birincil korumayı sağlamaktadır; ancak aşının aileler tarafından kabulü ve kullanımı için, disiplinin özelliği nedeniyle aile hekimince önerilmesi önemlidir. Hekimin bilgi düzeyi, aşının önerilmesini etkileyebilir. Amacımız birinci basamakta çalışan hekimlerinin serviks kanseri ve HPV aşısı ile ilgi¬li bilgi düzeyini saptamaktır. Yöntem: Kesitsel tanımlayıcı olarak planlanan araştırma, izmir kentindeki aile sağlığı merkezlerinde çalışan hekimlerle yürütülmüştür. Katılımcılara demografik özellikleri, serviks kanseri ve HPV aşısı ile ilgili 18 bilgi sorusunu kapsayan bir soru formu uygulanmıştır. Araştırma verileri SPSS 15.0 programında ki-kare, t-testi ve ANOVA ile analiz edilmiş, p<0.05 anlamlı kabul edilmiştir. Bulgular: Hekimlerin %61.3'ü erkektir, yaş ortalaması ve meslekteki ortalama süreleri sırasıyla 44.22±6.56 ve 19.37±6.34 yıldır. Hekimlerin %22'si kendilerine bağlı 15^49 yaş arası kadınlarda cinsel yolla bulaşan hastalığın sık olduğunu düşünmekle birlikte %30.7'si HPV aşısını gereksinimi olan gruba hiç önermemektedir. Hekimlerin %72.0'si maliyeti aşı uygulamasının önündeki en önemli engel olarak görmektedir. Hekimlerin toplam bilgi puanı 18 puan üzerinden ortalama 7.29±3.02 bulunmuştur. Sonuç: Hekimlerin HPV aşısı ile ilgili doğru tutum ve davranış geliştirmeleri için bilgilendirilmeleri gereklidir.

REFERENCES

References: 

1. WHO. Comprehensive cervical cancer control: a guide to essential practice, 2006. http://www.who.int/reproductivehealth/publications/cervi-cal_cancer_gep/... adresinden 02.11.2010 tarihinde erişilmiştir.
2.
Özgü
l N. Türkiye'de serviks kanserinin durumu ve kanser kontrol çalışmaları. Türkiye'de Kanser Kontrolü'nde. Ed. Tuncer AM. Ankara, Sağlık Bakanlığı Yayınları 2007;349-58.
3. Turkish Cervical Cancer And Cervical Cytology Research Group. Prevalence of cervical cytological abnormalities in Turkey. Int J Gynaecol Obstet 2009;106:206-9.
4. American Cancer Society Guideline for human papillomavirus (HPV) vac¬cine use to prevent cervical cancer and its precursors. CA Cancer J Clin 2007;57:7-28.
5. Koutsky L. Epidemiology of genital human papillomavirus infection. Am J Med 1997;102:3.
6. Ho GY, Palan PR, Basu J ve ark. Viral characteristics of human papillo-mavirus infection and antioxidant levels as risk factors for cervical dysplasia.
Int J Cancer 1998;78:594.
7. Kotloff KL, Wasserman SS, Russ K ve ark. Detection of genital human papillomavirus and associated cytological abnormalities among college women. Sex Transm Dis 1998;25:243.
8. Harper DM, Williams KB. Prophylactic HPV vaccines: current knowledge of impact on gynecologic premalignancies. Discov Med 2010;10:7-17.
9. CDC. Reports of Health Concerns Following HPV Vaccination. http://www.cdc.gov/vaccinesafety/vaccines/hpv/gardasil.html adresinden 20.10.2010 tarihinde erişilmiştir.
10. Aras S, Orcin E, Ozan S, Semin S. Sexual behaviours and contraception among university students in Turkey. J Biosoc Sci2007;39:121-35.
11. Brewer NT, Gottlieb SL, Reiter PL ve ark. Longitudinal predictors of human papillomavirus vaccine initiation among adolescent girls in a high-risk geographic area. Sex Transm Dis2010;38:197-204.
12. Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theo¬ry-informed, systematic review. Prev Med 2007;45:107-14.
13. Zimet GD, Weiss TW, Rosenthal SL, Good MB, Vichnin MD. Reasons for non-vaccination against HPV and future vaccination intentions among
19-26 year-old women. BMC Womens Health2010;1:27.
14. Duval B, Gilca V, McNeil S ve ark. Vaccination against human papillo-mavirus: a baseline survey of Canadian clinicians' knowledge, attitudes and
beliefs. Vaccine 2007;25:7841-7.
15. Ishibashi KL, Koopmans J, Curlin FA, Alexander KA, Ross LF. Paediatricians' attitudes and practices towards HPV vaccination. Acta
Paediatr 2008;97:1550-6.
16. Daley MF, Liddon N, Crane LA ve ark. A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination.
Pediatrics2006;118:2280-9.
17. Riedesel JM, Rosenthal SL, Zimet GD ve ark. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol
2005;18:391-8.
18. Jain N, Irwin KL, Montano D ve ark. Family physicians' knowledge of gen¬ital human papillomavirus (HPV) infection and HPV-related conditions, United States, 2004. Fam Med 2006;38:483-9.
19. Daley MF, Crane LA, Markowitz LE ve ark. Human papillomavirus vacci¬nation practices: a survey of US physicians 18 months after licensure.
Pediatrics2010;126:425-33.
20. Chow SN, Soon R, Park JS ve ark. Knowledge, attitudes, and communica¬tion around human papillomavirus (HPV) vaccination among urban Asian mothers and physicians. Vaccine2010;28:3809-17.
21. Ko EM, Missmer S, Johnson NR. Physician attitudes and practice toward human papillomavirus vaccination. J Low Genit Tract Dis 2010;14:339-45.

Thank you for copying data from http://www.arastirmax.com